SuPrecision™ Platform

Next-generation sequencing (NGS) plays an important role in cancer diagnostics. Creative Biolabs offers SuPrecision™ Platform covering a full range of NGS-based services. This tool greatly improves our understanding of the multifaceted disease and achieves accurate, sensitive, high-throughput and cost effective cancer detection.

  • Targeted sequencing

    Targeted sequencing is a next-generation sequencing (NGS) technique focusing on amplicons and specific genes. It is useful in population genetics since it can target a large diversity of organisms.

  • Whole exome sequencing

    Whole exome sequencing provides coverage of more than 95% of the exons, which harbor the majority of the genetic variants associated with human disease phenotypes, making WES a cost-effective alternative to whole-genome sequencing.

  • Whole transcriptome sequencing

    Whole transcriptome sequencing enables discovery and profiling of RNAs without prior genome annotation. It's an important tool in solving biological issues and understanding the molecular mechanisms of many diseases including human cancers.

  • Immune repertoire sequencing

    High-throughput next-generation sequencing to profile T- and B-cell receptor repertoires. Advanced methodology was implemented to elucidate the sophisticated immuno-bioinformatic analyses for clinical development of antibody engineering, vaccine design, and cellular immunotherapy.

  • Bioinformatics analysis

    Creative Biolabs offers high-quality custom bioinformatics analysis service for researchers and clinicians. Features of our service include high resolution, cost effective, unprecedented speed, etc.

  • Applications

    NGS in genomic medicine has been driven by low cost, high throughput sequencing and rapid advances in our understanding of the genetic bases of human diseases. The NGS-based method has dominated sequencing space in genomic research, and quickly entered clinical practice.

Inquiry Basket